Monsanto, famous for developing new strains of seeds and helping farmers improve their crop yields, has received US approval to test its new drought-tolerant biotech crop
Brain project gets scientists thinking
Henry Markram, the renowned electrophysiologists, is pursuing funding for a controversial creation
Glaxo licenses Amicus’ Fabry disease drug
GSK take another leap into biotech network with new support for early stage developmental drug
MORE ARTICLES
Are US regulators dropping the ball?
Robert Kremer, microbiologist who studies Midwestern farm soil, has spent two decades analysing dirt
Posted in BiotechnologyRead more
Africa heralds biofuel pipeline success
Billions of dollars pumped into African biofuel industry, mimics rest of the world as more to come
Posted in BiotechnologyRead more
The rasping chill of the agent of change
Although the biotech industry may have deep North American roots, it’s coming to Europe, big-time
Posted in BiotechnologyRead more
US flu plan cuts red tape, rewards biotechs
The US government has released a new plan for cutting red tape and working more closely with biotechs
Posted in BiotechnologyRead more
Acting with god working on our side
Straddling healthcare and science, innovative biotech companies are discovering huge opportunities
Posted in BiotechnologyRead more
Brazil’s biofuels campaign
Backing farmers will help avoid problems associated with the ethanol sector, including growing concentration in the hands of large agribusiness
Posted in BiotechnologyRead more
India’s biosciences ready to fly
India’s food sector is set to explode. Rajiv Gandhi, head of Hester Biosciences, knows animal biosciences inside out